Cognition Therapeutics, Inc. (CGTX) vs Rallybio Corporation (RLYB)
A side-by-side comparison of Cognition Therapeutics, Inc. and Rallybio Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGTX
Cognition Therapeutics, Inc.
$0.94HealthcareDelayed quote: Oct 6, 2026, 1:20 PM EDT
RLYB
Rallybio Corporation
$17.02HealthcareDelayed quote: Oct 6, 2026, 1:01 PM EDT
Total return — CGTX vs RLYB
growth of $100 · dividends reinvested · last 5yCGTX -92.7% (-40.7%/yr)RLYB -88.1% (-34.7%/yr)RLYB compounded faster over this window
CGTX RLYB
CGTX vs RLYB: by the numbers
- •RLYB is the larger company ($90M vs $84M market cap).
- •RLYB is profitable (7051.24% net margin) while CGTX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CGTX | RLYB |
|---|---|---|
| P/E ratio | N/A | 2.18 |
| P/S ratio | N/A | 139.82 |
| P/B ratio | 2.55 | 0.96 |
| FCF yield | N/A | 29.16% |
Profitability
| Metric | CGTX | RLYB |
|---|---|---|
| Gross margin | 0.00% | 89.28% |
| Operating margin | 0.00% | -3270.86% |
| Net margin | 0.00% | 7051.24% |
| ROE | -50.80% | 48.20% |
| ROIC | -109.43% | -24.40% |
Growth (annualized)
| Metric | CGTX | RLYB |
|---|---|---|
| Total return CAGR (5Y) | N/A | -35.80% |
Frequently asked
- Is CGTX or RLYB more profitable?
- RLYB runs the higher net margin — CGTX at 0.00% versus RLYB at 7051.24%.
Go deeper
Dig into the metrics
Rallybio P/E ratioCognition Therapeutics ROERallybio ROECognition Therapeutics operating marginRallybio operating marginCognition Therapeutics revenue growthRallybio revenue growthCognition Therapeutics free cash flowRallybio free cash flow
Cognition Therapeutics & Rallybio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.